Disc Medicine (IRON) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
18 Jun, 2026Opening remarks and agenda
The meeting was called to order by the Executive Chairman, with directors and key executives recognized in attendance.
The agenda included formal business as described in the notice and proxy statement sent to stockholders.
Representatives from the audit firm and outside counsel were present.
Corporate governance
Quorum was established with over 35.9 million shares represented out of 38.2 million entitled to vote.
Voting procedures were explained, and polls were opened for stockholder participation.
Only stockholders with valid credentials could vote and ask questions.
Board and executive committee updates
Three nominees were presented for election as Class III directors for a three-year term, with no alternative nominations received.
The board unanimously recommended the election of the nominated directors.
Latest events from Disc Medicine
- Bitopertin and selcodebart show strong, durable efficacy, with pivotal data expected in Q4 2026.IRON
Study update15 Jun 2026 - Pivotal data and regulatory milestones for key anemia programs are expected by year-end.IRON
Jefferies Global Healthcare Conference 20263 Jun 2026 - Late-stage pipeline targets EPP, MF anemia, and PV with pivotal data expected by 2027.IRON
Corporate presentation3 Jun 2026 - APOLLO study enrollment exceeded targets, signaling high demand and unmet need for EPP therapies.IRON
H.C. Wainwright 4th Annual BioConnect Investor Conference19 May 2026 - Net loss widened to $63.5M as bitopertin's FDA review was delayed; cash runway extends to 2029.IRON
Q1 20265 May 2026 - Proxy covers director elections, say-on-pay, auditor ratification, and performance-based compensation.IRON
Proxy filing29 Apr 2026 - Director elections, executive pay, and auditor ratification up for vote at June 2026 meeting.IRON
Proxy filing28 Apr 2026 - Phase III data for bitopertin and key pipeline readouts are expected by year-end.IRON
Leerink Global Healthcare Conference 20269 Mar 2026 - Multiple late-stage programs advance toward pivotal data and regulatory milestones in 2024.IRON
TD Cowen 46th Annual Health Care Conference3 Mar 2026